ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Complaints Are “Astonishingly Far From Facts,” But NCI May Be Leaving Good Science Unfunded

April 29, 1977

AHRQ Funds Research To Reduce Medical Errors.

October 19, 2001

CCOP Controversy Goes On: DCT Board Objects, Says It Was Left Out; Moorhead, DeVita Clarify Positions

February 19, 1982

In Brief: AACR Award Lectures, Announced; Hungerford Honored for Philadelphia Chromosome Discovery

April 20, 1990

Funding Opportunities

October 4, 2002

Breast Cancer Death Rates Improving, NCI Says

May 10, 1996